attachment
attachment

These are my physiology practical topics tell me questions which are probable for viva in my physiology exam

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here are the most commonly asked viva questions for each of your hematology practicals. These are standard questions examiners in physiology practicals repeatedly ask.

1. Estimation of Haemoglobin Content of Blood

  • What is the principle of Sahli's (acid hematin) method?
  • What is the normal Hb value in adult males, females, and newborns?
  • Why is 0.1 N HCl used in Sahli's method? What happens if it is too weak/strong?
  • Why do we wait 10 minutes before comparing color in acid hematin method?
  • What are the sources of error in Sahli's method?
  • Name other methods of Hb estimation (Cyanmethemoglobin/Drabkin's method, colorimetric methods). Which is the gold standard and why?
  • What is the color of acid hematin? Why is it brown, not red?
  • What is anemia? Classify anemia based on Hb/MCV.
  • What is the relationship between Hb, RBC count, and PCV (calculate MCHC/color index)?
  • Why is capillary blood (finger prick) preferred over venous blood for this test?
  • What anticoagulant is used for blood collection, and why?

2. W.B.C. Count Study Using Neubauer Chamber (Total Leukocyte Count)

  • What is the principle of a hemocytometer/Neubauer chamber?
  • What diluting fluid is used for WBC count and why (e.g., Turk's fluid/dilute acetic acid)? Why does it lyse RBCs but not WBCs?
  • What is the dilution used for WBC counting?
  • Which squares/areas of the counting chamber are used for WBC count?
  • What is the formula for calculating total WBC count from the number of cells counted?
  • What is the normal total leukocyte count?
  • Define leukocytosis and leukopenia; give causes of each.
  • What are the depth and area specifications of the Neubauer chamber (why the constant "10" is used)?
  • Sources of error in WBC counting (improper dilution, bubbles, uneven distribution, chamber not clean/dry).
  • Why do we discard the first drop of blood in a finger prick?

3. R.B.C. Count

  • What diluting fluid is used for RBC count (Hayem's solution) and why?
  • What is the dilution factor used for RBC counting?
  • Which squares of the Neubauer chamber are counted for RBC (the 5 central squares of the central square millimeter)?
  • What is the normal RBC count in males and females?
  • What is polycythemia and its causes? What is the difference between primary and secondary polycythemia?
  • Define erythropenia/anemia and its causes.
  • What is erythropoietin and where is it produced?
  • What is the lifespan of an RBC, and where are they destroyed?
  • Formula used to calculate RBC count from counted cells.
  • Why can't Turk's fluid be used for RBC counting?

4. Determination of Blood Groups

  • What is the basis of ABO blood grouping (Landsteiner's Law)?
  • What antigens and antibodies are present in each blood group (A, B, AB, O)?
  • What is the universal donor and universal recipient, and why?
  • What is the Rh factor? Why is it clinically important (Rh incompatibility, hemolytic disease of the newborn/erythroblastosis fetalis)?
  • What is agglutination and what causes it?
  • Difference between agglutination and clumping/rouleaux formation.
  • What antisera are used (anti-A, anti-B, anti-D) and how do you interpret the reactions?
  • What precautions must be taken before a blood transfusion (cross-matching, major and minor)?
  • Why is blood grouping important before transfusion, and what happens with a mismatched transfusion (transfusion reaction, hemolysis)?
  • What is the Bombay blood group?
  • Frequency/distribution of blood groups in the population.

5. Differential W.B.C. Count (DLC)

  • Name the five types of WBCs and their normal percentages (neutrophils, lymphocytes, eosinophils, monocytes, basophils).
  • What is a "leishman stain" or "Leishman's method" used for peripheral smear staining? What is the principle?
  • What is the "battlement method" of counting cells on a smear and why is it used?
  • Define neutrophilia, neutropenia, lymphocytosis, eosinophilia and give causes for each.
  • What is a "shift to the left" in neutrophil count and its significance (bandemia in infection)?
  • What is the functional significance of each WBC type (neutrophils - phagocytosis, eosinophils - allergy/parasitic infections, basophils - histamine/heparin, lymphocytes - immunity, monocytes - phagocytosis/antigen presentation)?
  • Difference between Total leukocyte count and Differential leukocyte count.
  • What is a normal absolute eosinophil count, and what conditions raise it?
  • Why is a thin, well-spread smear necessary for DLC?

6. Determination of Bleeding Time and Coagulation Time

  • Define bleeding time (BT) and clotting time (CT). What is the difference between them physiologically?
  • What is the normal range of BT (Duke's method ~1-6 min, Ivy's method ~1-9 min) and CT (capillary tube method ~3-8 min)?
  • What is the principle of Duke's method vs Ivy's method for BT?
  • Which vessels/mechanism does BT test (platelets and vascular response) and which does CT test (coagulation cascade/clotting factors)?
  • What are the stages/phases of hemostasis (vascular spasm, platelet plug formation, coagulation, fibrinolysis)?
  • Outline the coagulation cascade - intrinsic, extrinsic, and common pathways.
  • Role of platelets, calcium, and vitamin K in coagulation.
  • What is prolonged BT seen in (thrombocytopenia, von Willebrand disease, aspirin use)?
  • What is prolonged CT seen in (hemophilia, severe liver disease, anticoagulant therapy, vitamin K deficiency)?
  • What is the role of thromboplastin, prothrombin, fibrinogen, and fibrin in clotting?
  • Why is capillary blood used and why must the tube be broken every 30 seconds in the capillary tube method for CT?
  • What are anticoagulants (heparin, warfarin, EDTA, sodium citrate) and their mechanisms of action?

General/Cross-cutting questions examiners often ask across all hematology practicals

  • Why is a lancet/finger-prick used, and how do you clean the site (spirit, not povidone-iodine, which can hemolyze cells)?
  • What are the functions of blood?
  • What is the composition of plasma vs serum, and how do they differ?
  • What anticoagulants can be used in blood collection and how each works (EDTA for CBC, heparin, sodium citrate)?
  • What is PCV/hematocrit, and how do Hb, RBC count, and PCV relate (calculating MCV, MCH, MCHC)?
If you want, tell me which single practical you have your viva on first (or is most important), and I can go deeper with expected answers, diagrams, and likely follow-up questions for that one.

Answer every question

Here are complete answers to all the viva questions listed for each practical.

1. Estimation of Haemoglobin Content of Blood

Principle of Sahli's method: Hemoglobin is converted to acid hematin (brown color) by adding 0.1 N HCl. The brown color is then diluted with distilled water, drop by drop, until it matches the color of the permanent brown glass standard on the comparator. The amount of water added is inversely related to Hb concentration, and the scale is read directly in g/dL.
Normal Hb values: Adult male 13-17 g/dL (avg ~15 g/dL); adult female 12-15 g/dL (avg ~13.5 g/dL); newborn 14-20 g/dL (higher due to intrauterine hypoxia stimulating erythropoietin).
Why 0.1 N HCl: This strength is just enough to convert Hb to acid hematin completely within the reaction time. If too weak, conversion is incomplete (falsely low reading); if too strong, it can cause turbidity/errors, and simply doesn't improve accuracy since acid hematin formation is already complete at 0.1 N.
Why wait 10 minutes: Acid hematin formation is a time-dependent reaction; the brown color takes about 10 minutes to fully develop and stabilize. Reading before that underestimates Hb.
Sources of error: Improper cleaning of pipette, air bubbles in pipette, incomplete mixing, subjective/observer error in colour matching, faded/scratched comparator glass, poor lighting, hemolyzed or clotted blood sample, using a colour-blind observer.
Other methods: Cyanmethemoglobin (Drabkin's) method - Hb converted to cyanmethemoglobin, read on a photoelectric colorimeter at 540 nm; this is the internationally accepted reference/gold standard because it is objective, accurate, and stable, avoiding the subjective color-matching error of Sahli's method. Other methods: oxyhemoglobin method, specific gravity method (copper sulfate method - used in blood donor screening), automated cell counters (electronic impedance/laser).
Color of acid hematin: Brown, because Hb (iron in ferrous/Fe2+ state, red color) is converted by HCl to acid hematin where iron is oxidized/changed in its binding, giving a brown pigment - not red as in oxyhemoglobin.
Anemia: Reduction in Hb concentration, RBC count, or PCV below normal for age and sex, reducing oxygen-carrying capacity. Classified by cell size (MCV) into microcytic (iron deficiency, thalassemia), normocytic (hemolytic, aplastic, acute blood loss), and macrocytic (B12/folate deficiency); also by etiology into deficiency, hemolytic, aplastic, and hemorrhagic anemia.
Relationship of Hb, RBC, PCV: Color index (CI) = (Hb% patient / Hb% normal) / (RBC count patient / RBC count normal). MCHC = Hb (g/dL) x 100 / PCV (%); normal MCHC is 32-36 g/dL. These indices help classify anemia as normochromic, hypochromic, or hyperchromic.
Why capillary/finger-prick blood: Easy, minimally invasive, sufficient volume for microscale tests, avoids venipuncture complications for a simple screening test; however capillary blood has slightly higher Hb than venous blood due to more RBCs from tissue fluid loss/evaporation and arteriolar admixture.
Anticoagulant used: EDTA (ethylenediaminetetraacetic acid) is standard for CBC/Hb estimation because it chelates calcium, prevents clotting without altering cell morphology or size, unlike heparin (can cause clumping) or citrate (used for coagulation studies, not CBC).

2. W.B.C. Count Using Neubauer Chamber

Principle of hemocytometer: A thick glass slide with an etched grid of known area and a precisely controlled depth (0.1 mm) beneath a coverslip, allowing counting of cells in a known volume of diluted blood, from which the concentration of cells per liter/microliter of undiluted blood can be calculated.
Diluting fluid for WBC (Turk's fluid): Contains dilute (1-3%) acetic acid and gentian violet. The acetic acid lyses/hemolyzes RBCs (since RBCs lack a rigid nucleus/wall and osmotically fragile in acid) so they don't obscure the count, while WBCs (having a nucleus, more robust) survive and are stained faintly by gentian violet for visibility.
Dilution: Usually 1:20 (blood drawn to the 0.5 mark, diluting fluid to the 11 mark in a WBC pipette).
Chamber area used: The 4 corner large squares (each 1 mm x 1 mm, subdivided into 16 smaller squares), total area 4 sq mm, at a depth of 0.1 mm.
Formula: WBC/µL = Number of cells counted x dilution factor / volume counted (mm³) = N x 20 / (4 x 0.1) = N x 50.
Normal TLC: 4,000-11,000 cells/µL (4-11 x 10^9/L).
Leukocytosis: Raised WBC count - causes: bacterial infection, inflammation, stress, leukemia, steroid therapy, tissue necrosis, physiological (exercise, pregnancy, newborns). Leukopenia: Low WBC count - causes: viral infections (typhoid, influenza), bone marrow depression/aplasia, radiation, certain drugs (chemotherapy), autoimmune disease (SLE), severe sepsis.
Depth/area constant: Depth is 0.1 mm, and dividing by this small volume (with dilution factor) is why the multiplication constant "50" (or "10" is used in some contexts for other steps) appears in the formula - it converts the count in a tiny volume into a per-microliter/per-liter value.
Sources of error: Improper/incomplete mixing of diluting fluid, air bubbles, uneven cell distribution on chamber, wet or dirty chamber/coverslip, pipette not rinsed, clotted sample, counting cells at chamber lines inconsistently (rule: count cells touching top and left lines, exclude bottom and right).
Discard first drop: The first drop contains tissue fluid and may have platelet clumping from the puncture trauma, which would give inaccurate cell counts; the second free-flowing drop is used.

3. R.B.C. Count

Diluting fluid (Hayem's solution): Contains sodium chloride, sodium sulfate, and mercuric chloride, and is isotonic, so it preserves RBC shape and prevents lysis, while mercuric chloride acts as a preservative/fixative preventing rouleaux formation and bacterial growth.
Dilution: Usually 1:200 (blood to 0.5 mark, Hayem's fluid to the 101 mark in RBC pipette).
Squares counted: The central 1 sq mm square, specifically the 5 smaller squares within it (4 corner squares + 1 central square of the 25 subdivisions), each further divided into 16 smallest squares - total 80 smallest squares counted, at 0.1 mm depth.
Normal RBC count: Males: 4.5-6.0 million/µL; Females: 4.0-5.5 million/µL.
Polycythemia: Increased RBC count. Primary (polycythemia vera) - a myeloproliferative neoplasm with autonomous marrow overproduction. Secondary - physiological compensatory response to hypoxia (high altitude, chronic lung/heart disease, smoking) via increased erythropoietin.
Erythropenia/anemia causes: Blood loss, hemolysis, deficient erythropoiesis (iron/B12/folate deficiency), bone marrow failure (aplastic anemia), chronic kidney disease (reduced erythropoietin).
Erythropoietin: A glycoprotein hormone produced mainly by the kidney (peritubular interstitial cells), in response to tissue hypoxia, stimulating RBC production in bone marrow.
RBC lifespan: Approximately 120 days; destroyed mainly in the spleen (and liver) by macrophages of the reticuloendothelial system (extravascular hemolysis).
Formula: RBC/µL = Number of cells counted x dilution factor / volume counted (mm³) = N x 200 / (80 x 0.1) x 5 (adjust per exact squares/volume convention) - commonly simplified as N x 10,000 when counting 80 smallest squares at 1:200 dilution and 0.1 mm depth.
Why Turk's fluid can't be used for RBC: It lyses RBCs (that's its purpose for WBC counting), so it would destroy the very cells being counted in an RBC count.

4. Determination of Blood Groups

Landsteiner's Law: If a particular antigen is present on the RBC, the corresponding antibody must be absent from that person's plasma (and vice versa), otherwise autoagglutination/hemolysis would occur. This underlies the reciprocal relationship between antigens on RBCs and antibodies in plasma across the four ABO groups.
Antigens/antibodies per group:
  • Group A: A antigen on RBC; anti-B antibody in plasma
  • Group B: B antigen on RBC; anti-A antibody in plasma
  • Group AB: both A and B antigens; no antibodies (universal recipient for RBCs)
  • Group O: no antigens; both anti-A and anti-B antibodies (universal donor for RBCs)
Universal donor/recipient: O negative is the universal donor (no A, B, or Rh(D) antigen to trigger a reaction in any recipient). AB positive is the universal recipient (has no anti-A, anti-B antibodies and already has Rh(D) antigen, so can receive any blood type without immediate antigen-antibody reaction against donor RBCs).
Rh factor: The D antigen on RBC surface; about 85% of people are Rh positive. Clinically important because Rh-negative individuals exposed to Rh-positive blood (transfusion or pregnancy) can develop anti-D antibodies (sensitization), which in a subsequent pregnancy can cross the placenta and cause hemolytic disease of the newborn (erythroblastosis fetalis) in an Rh-positive fetus.
Agglutination: Clumping of RBCs caused by antibodies (agglutinins) cross-linking antigens (agglutinogens) on multiple RBCs, forming visible clumps - the basis for blood group typing.
Agglutination vs rouleaux: Agglutination is irregular clumping from antigen-antibody binding and does not disperse; rouleaux formation is a reversible, stack-of-coins-like alignment of RBCs (seen in high plasma protein/fibrinogen states or with certain diluents) that disperses on dilution/shaking and is not immune-mediated.
Antisera interpretation: Anti-A agglutinates group A cells; anti-B agglutinates group B cells; anti-D (anti-Rh) agglutinates Rh-positive cells. Reading: agglutination with anti-A only = Group A; anti-B only = Group B; both = Group AB; neither = Group O; agglutination with anti-D = Rh positive, no agglutination = Rh negative.
Precautions before transfusion: ABO and Rh typing of both donor and recipient, major cross-matching (donor RBCs + recipient serum) and minor cross-matching (donor serum + recipient RBCs), antibody screening, checking expiry and storage of blood, correct patient identification, slow initial infusion rate while monitoring for reaction.
Mismatched transfusion: Causes acute hemolytic transfusion reaction - antibody-mediated intravascular hemolysis, releasing free Hb, causing fever, chills, back pain, hypotension, hemoglobinuria, and can progress to acute kidney injury (from acid hematin blocking renal tubules) and disseminated intravascular coagulation (DIC), which can be fatal.
Bombay blood group: A rare phenotype where individuals lack the H antigen (precursor for A and B antigens) due to a defective FUT1 gene, so even if they carry A or B genes they cannot express A/B antigens; their RBCs type as O on routine ABO testing but they have anti-A, anti-B, and anti-H antibodies, so they can only receive blood from other Bombay phenotype donors.
Population distribution (approx., varies by region): O > A > B > AB in most populations (India: roughly B > O > A > AB, but O is generally most common worldwide).

5. Differential W.B.C. Count (DLC)

Five WBC types and normal %: Neutrophils 40-75% (children), 50-70% typical adult; Lymphocytes 20-45% (higher in children); Eosinophils 1-6%; Monocytes 2-10%; Basophils 0-1%.
Leishman staining principle: A Romanowsky-type stain (methanol-based, containing methylene blue and eosin). Methanol fixes cells; the stain differentially colors cellular components - acidic components (like nucleic acids/nucleus) stain blue-purple with the basic dye (methylene blue), while basic components (like hemoglobin, eosinophil granules) stain pink/red/orange with the acidic dye (eosin), allowing clear differentiation of cell types.
Battlement method: A systematic zig-zag counting pattern moving along the edges/border of the smear (avoiding the very thick or very thin areas) to ensure a representative, unbiased sample of 100 cells is counted across the slide, since cell distribution varies with smear thickness (larger cells like monocytes/neutrophils tend to be pushed to edges).
Definitions and causes:
  • Neutrophilia (raised neutrophils): acute bacterial infection, inflammation, stress, tissue necrosis, corticosteroid therapy.
  • Neutropenia: viral infections, bone marrow suppression, some drugs, severe sepsis (consumption), autoimmune destruction.
  • Lymphocytosis: viral infections (EBV, CMV), chronic infections (TB), chronic lymphocytic leukemia.
  • Eosinophilia: allergic conditions (asthma, atopic dermatitis), parasitic infections, drug reactions.
Shift to the left: Increased proportion of immature neutrophil forms (band cells/bands, sometimes even more immature forms) in the peripheral blood, indicating an intense bone marrow response, classically seen in acute bacterial infections/sepsis.
Functional significance:
  • Neutrophils - first responders, phagocytose bacteria (acute inflammation).
  • Eosinophils - defend against parasites, modulate allergic/hypersensitivity reactions.
  • Basophils - release histamine and heparin, mediate immediate hypersensitivity.
  • Lymphocytes - adaptive immunity (B cells - antibody production; T cells - cell-mediated immunity).
  • Monocytes - phagocytosis, differentiate into tissue macrophages, antigen presentation.
TLC vs DLC: TLC gives the absolute total number of all WBCs per unit volume of blood; DLC gives the relative percentage distribution of the different WBC types among 100 counted cells on a stained smear - DLC does not tell you absolute numbers unless combined with the TLC (absolute count = TLC x % of that cell type).
Normal absolute eosinophil count: Roughly 40-400/µL (varies by reference); raised in allergic diseases, parasitic (helminthic) infections, certain drug reactions, and some skin diseases.
Why a thin, well-spread smear: Ensures a monolayer of cells so cell morphology, staining, and distribution are accurately visualized without overlapping cells causing miscounting or misidentification.

6. Determination of Bleeding Time and Coagulation Time

Definitions: Bleeding time (BT) is the time from a standardized skin puncture until bleeding spontaneously stops - reflects platelet plug formation and vascular response (primary hemostasis). Coagulation/clotting time (CT) is the time taken for blood to clot in a capillary tube/glass surface - reflects the full coagulation cascade (secondary hemostasis).
Normal ranges: BT by Duke's method: 1-6 minutes (some texts up to 9 min); BT by Ivy's method: 1-9 minutes (considered more standardized/reliable as it controls pressure). CT by capillary tube method: 3-8 minutes (varies by textbook, roughly 3-11 min).
Duke's vs Ivy's method: Duke's method uses an ear lobe puncture with blotting paper every 30 seconds until bleeding stops - simple but less standardized (no controlled pressure). Ivy's method uses a forearm puncture with a sphygmomanometer cuff inflated to 40 mmHg to maintain constant venous pressure, giving more reproducible results.
Vessels/mechanism tested: BT tests vascular integrity, vasoconstriction, and platelet number/function (primary hemostasis). CT tests the intrinsic and common coagulation pathways leading to fibrin clot formation (secondary hemostasis).
Stages of hemostasis: 1) Vascular spasm (immediate vasoconstriction); 2) Platelet plug formation (adhesion, activation, aggregation); 3) Coagulation (fibrin clot formation via the coagulation cascade); 4) Fibrinolysis (clot dissolution/remodeling once healing occurs).
Coagulation cascade:
  • Intrinsic pathway: activated by contact with collagen/subendothelium - Factor XII to XI to IX to VIII to X.
  • Extrinsic pathway: activated by tissue factor (Factor III) released from damaged tissue - Factor VII to X.
  • Common pathway: Factor X (with Va) activates prothrombin (II) to thrombin, which converts fibrinogen (I) to fibrin, stabilized by Factor XIII into a cross-linked clot.
Role of platelets, calcium, vitamin K: Platelets provide the phospholipid surface for clotting factor assembly and form the initial plug. Calcium (Factor IV) is essential as a cofactor for multiple steps in the cascade (binding clotting factors to phospholipid surfaces). Vitamin K is required for hepatic synthesis of functional (gamma-carboxylated) Factors II, VII, IX, and X, and proteins C and S.
Prolonged BT causes: Thrombocytopenia (low platelet count), platelet dysfunction (von Willebrand disease, aspirin/NSAID use inhibiting platelet aggregation), severe vitamin C deficiency (scurvy, vascular fragility).
Prolonged CT causes: Hemophilia A/B (Factor VIII/IX deficiency), severe liver disease (reduced synthesis of clotting factors), vitamin K deficiency, anticoagulant therapy (heparin, warfarin), DIC (factor consumption).
Roles of key factors: Thromboplastin (tissue factor) initiates the extrinsic pathway; prothrombin is the inactive precursor converted to active thrombin; fibrinogen is the soluble plasma protein converted by thrombin into insoluble fibrin strands that form the structural clot mesh.
Why capillary blood and breaking tube every 30 sec: Capillary blood is easily obtained by finger prick for this bedside test; the tube is broken/checked every 30 seconds to detect the exact point when a fibrin thread/clot forms (visible as the blood column resists separation into two segments), marking the endpoint of clotting time.
Anticoagulants and mechanisms:
  • Heparin: potentiates antithrombin III, which inactivates thrombin and Factor Xa (acts in vivo and in vitro).
  • Warfarin: vitamin K antagonist, inhibits hepatic synthesis of Factors II, VII, IX, X (acts only in vivo).
  • EDTA: chelates calcium, preventing its role as a cofactor in the cascade (in vitro use only, for CBC samples).
  • Sodium citrate: also chelates calcium (used in blood bank storage and coagulation testing samples, reversible with calcium addition).

General/Cross-cutting Questions

Finger-prick/lancet site cleaning: Clean with spirit (70% alcohol) and let it dry before puncture; povidone-iodine is avoided because residual iodine can interfere with certain chemical reactions and can cause hemolysis or false results in some tests, and alcohol residue itself must be allowed to evaporate to prevent hemolysis of the sample.
Functions of blood: Transport (oxygen, carbon dioxide, nutrients, hormones, waste), regulation (pH, temperature, fluid balance/osmotic pressure), protection (immunity via WBCs and antibodies, hemostasis/clotting to prevent blood loss).
Plasma vs serum: Plasma is the fluid portion of blood obtained after centrifuging anticoagulated (unclotted) whole blood - it contains all clotting factors including fibrinogen. Serum is the fluid remaining after blood is allowed to clot and the clot (with cells and fibrin) is removed - it lacks fibrinogen and other clotting factors consumed during coagulation.
Anticoagulants for collection:
  • EDTA: chelates calcium; used for CBC (preserves cell morphology, prevents clumping).
  • Heparin: potentiates antithrombin III; used for blood gas analysis, some biochemistry tests; not ideal for blood smears (can cause artifact).
  • Sodium citrate: chelates calcium reversibly; used for coagulation studies (PT, aPTT) and blood bank storage, because calcium can be added back to reverse the effect for testing.
PCV and indices relationship: PCV (hematocrit) is the percentage of blood volume occupied by RBCs (normal ~40-50% male, 36-46% female). Combined with RBC count and Hb, you calculate MCV (mean corpuscular volume) = PCV x 10 / RBC count (in millions/µL), MCH (mean corpuscular hemoglobin) = Hb x 10 / RBC count, and MCHC = Hb x 100 / PCV - together these classify anemia type (microcytic/normocytic/macrocytic, hypochromic/normochromic).
If you want, I can convert this into a printable revision sheet (PDF/Word) for quick last-minute review before your viva.
This is a shared conversation. Sign in to Orris to start your own chat.